HK Stock MarketDetailed Quotes

01952 EVEREST MED-B

Watchlist

49.000
+1.600+3.38%

Market Closed Dec 16 16:08 CST

15.98BMarket Cap-13.84P/E (TTM)

EVEREST MED-B Stock Forum

Moomoo AI

Mar 17 21:32

CEO of Everest Medicines, Rogers Yongqing Luo, is confident that the appointments of Ms. Zeng and Mr. Liang will expedite the company's strategic growth. They are anticipated to spearhead their teams and foster strategic integration, promoting successful commercialization of Everest's products and long-term value creation.

Press Release: Everest Medicines Strengthens Management Team With Appointments of Chief Medical Officer and Chief Product Officer

Spinee

Jan 17 02:21

HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off

$Hang Seng Index (800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ ...

102252270

Jul 20, 2022 21:28

$EVEREST MED-B (01952.HK)$ soon to be hkd 30 ?

102252270

Jul 19, 2022 20:47

$EVEREST MED-B (01952.HK)$ will potebtially reap benefits from new Covid vaccine approval by FDA

Dabria

Sep 14, 2021 07:11

$EVEREST MED-B (01952.HK)$ On September 13, Genting Sunshine announced that it would introduce Providence's mRNA COVID-19 vaccine at a total price of 2.583 billion yuan, and the two parties will also cooperate in the development of two mRNA vaccines in the future.

No comment yet

Heat List

Overall

No Data

Investment Theme

Pharmaceutical Companies

Intraday-1.87%